Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Guillamet, E.
Right arrow Articles by Marcos, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guillamet, E.
Right arrow Articles by Marcos, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Mutagenesis vol. 19 no. 2 pp. 129-135, March 2004
© 2004 UK Environmental Mutagen Society/Oxford University Press

In vitro DNA damage by arsenic compounds in a human lymphoblastoid cell line (TK6) assessed by the alkaline Comet assay

Emma Guillamet, Amadeu Creus, Jessica Ponti1, Enrico Sabbioni1, Salvador Fortaner1 and Ricardo Marcos2

Grup de Mutagènesi, Departament de Genètica i de Microbiologia, Facultat de Ciències, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain and 1European Commission, Institute for Health and Consumer Protection, ECVAM Unit, Joint Research Centre, 21020 Ispra, Italy

Arsenic is classified as a carcinogen for humans, but as a possible genotoxic agent. Thus, taking into account the controversial data about how arsenic compounds are able to induce genetic damage, we investigated the possible genotoxic activity of different arsenic compounds in the TK6 human lymphoblastoid cell line using the alkaline Comet assay. Eight different inorganic and organic arsenical compounds have been selected as follows: three inorganic (sodium arsenite, sodium arsenate and sodium hexafluorarsenate) and five organic (monomethylarsonic and dimethylarsinic acids, arsenobetaine, tetramethylarsonium iodide and tetraphenylarsonium chloride). According to their toxicity and genotoxicity, the highest concentration tested was 10 mM, and the duration of the treatments was 30 min or 3 h. The results indicate that some compounds belonging to both the organic and inorganic species were able to induce significant increases in the tail moment, the parameter used to determine genotoxicity. Thus, the inorganic compounds sodium arsenite and sodium arsenate (but not sodium hexafluoroarsenate) were genotoxic, while among the organoarsenic species tested only tetramethylarsonium iodide and tetraphenylarsonium chloride compounds (but not monomethylarsonic, dimethylarsinic acids and arsenobetaine) induced significant increases in the tail moment. Nevertheless, genotoxic induction was generally only observed at the highest doses tested.

2To whom correspondence should be addressed. Email: ricard.marcos{at}uab.es

Received on July 25, 2003; revised on October 13, 2003; accepted on October 20, 2003


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
International Journal of ToxicologyHome page
A. Wang, S. D. Holladay, D. C. Wolf, S. A. Ahmed, and J. L. Robertson
Reproductive and Developmental Toxicity of Arsenic in Rodents: A Review
International Journal of Toxicology, September 1, 2006; 25(5): 319 - 331.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
J. I. Gonzalez Borroto, G. Perez Machado, A. Creus, and R. Marcos
Comparative genotoxic evaluation of 2-furylethylenes and 5-nitrofurans by using the comet assay in TK6 cells
Mutagenesis, May 1, 2005; 20(3): 193 - 197.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. A. Bonzo, S. Chen, A. Galijatovic, and R. H. Tukey
Arsenite Inhibition of CYP1A1 Induction by 2,3,7,8-Tetrachlorodibenzo-p-dioxin Is Independent of Cell Cycle Arrest
Mol. Pharmacol., April 1, 2005; 67(4): 1247 - 1256.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.